Skip to main content
Premium Trial:

Request an Annual Quote

SurroMed Chooses Spotfire s Platform for Data Delivery

NEW YORK, Feb. 18 (GenomeWeb News) - SurroMed will use Spotfire's data analysis platform to share data with collaborators and customers interactively over the Internet, Spotfire said yesterday.


According to Somerville, Mass.-based Spotfire, its DecisionSite Posters platform will allow biomarker discovery company SurroMed, of Mountain View, Calif., to share live data and analytical results securely using a Web-based service.


The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.